WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 232
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 272

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 11  11  11  11  11 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Tuvalu)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  509 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tuvalu)
Vaccine year result method % card seen                                                
BCG 2006  84  DHS   33  99  99*  99*  99*  99*  99* 
DTP1 2006  78  DHS   33  99  99*  99*  99*  99*  80 
DTP3 2006  62  DHS   33  94  96  89  90  97  82 
DTP4          81  88 
IPV1          99  99* 
HepB_BD          99  98  99  97  99*  99* 
HepB3          94  96  89  90  97  81 
Hib3          94  96  89  90  97 
JapEnc         
MCV1          96  94  94  96  98  81 
MCV2          92  86  91  84  93 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2006  60  DHS   33  94  96  89  90  97  82 
Rota1         
RotaC         
RCV1          96  94  94  96  98 
TT2plus 2006  24  DHS   33  71  99*  99*  99*  99*  65 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tuvalu)
BCG
ChartChart
  98  99  99  99  99  99  96  99 
DTP1
ChartChart
  99  99  99  99  99  93  99  61 
DTP3
ChartChart
  94  96  89  90  97  82  99  36 
HepB3
ChartChart
  94  96  89  90  97  81 
HepB_BD
ChartChart
  99  98  99  97  99  99 
Hib3
ChartChart
  94  96  89  90  97 
MCV1
ChartChart
  96  94  94  96  98  81  95 
MCV2
ChartChart
  92  86  91  84  93 
PCV3
 
Pol3
ChartChart
  94  96  89  90  97  82  84  23 
RCV1
ChartChart
  96  94  94  96  98 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 63
From 80 to 89% 25
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 5-6 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 6, 10, 14 weeks; 12 months; Yes
MR 12, 18 months; Yes
TT 1st contact; +4 weeks; +6 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes    Yes  Yes  Yes  No 
What years does the MYP cover? number 2'016        2011-2012     
Nº of districts with microplans that include activities to raise immunization coverage number          

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 88  88    113  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 63  50    88  100  38  13 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes      Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes      Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%        

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR NA      No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.